These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 16115927

  • 1. Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence.
    Li H, Zhang Y, Glass A, Zellweger T, Gehan E, Bubendorf L, Gelmann EP, Nevalainen MT.
    Clin Cancer Res; 2005 Aug 15; 11(16):5863-8. PubMed ID: 16115927
    [Abstract] [Full Text] [Related]

  • 2. Signal transducer and activator of transcription-5 activation and breast cancer prognosis.
    Nevalainen MT, Xie J, Torhorst J, Bubendorf L, Haas P, Kononen J, Sauter G, Rui H.
    J Clin Oncol; 2004 Jun 01; 22(11):2053-60. PubMed ID: 15169792
    [Abstract] [Full Text] [Related]

  • 3. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L, Jones TD, Lin H, Eble JN, Zeng G, Carr MD, Koch MO.
    J Urol; 2005 Dec 01; 174(6):2181-5. PubMed ID: 16280760
    [Abstract] [Full Text] [Related]

  • 4. Visual estimation of tumour extent is not an independent predictor of prostate specific antigen recurrence.
    Jones TD, Koch MO, Lin H, Cheng L.
    BJU Int; 2005 Dec 01; 96(9):1253-7. PubMed ID: 16287440
    [Abstract] [Full Text] [Related]

  • 5. Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade.
    Li H, Ahonen TJ, Alanen K, Xie J, LeBaron MJ, Pretlow TG, Ealley EL, Zhang Y, Nurmi M, Singh B, Martikainen PM, Nevalainen MT.
    Cancer Res; 2004 Jul 15; 64(14):4774-82. PubMed ID: 15256446
    [Abstract] [Full Text] [Related]

  • 6. Reduced alpha- and beta-catenin expression predicts shortened survival in local prostate cancer.
    Aaltomaa S, Kärjä V, Lipponen P, Isotalo T, Kankkunen JP, Talja M, Mokka R.
    Anticancer Res; 2005 Jul 15; 25(6C):4707-12. PubMed ID: 16334164
    [Abstract] [Full Text] [Related]

  • 7. Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer.
    Han KR, Seligson DB, Liu X, Horvath S, Shintaku PI, Thomas GV, Said JW, Reiter RE.
    J Urol; 2004 Mar 15; 171(3):1117-21. PubMed ID: 14767283
    [Abstract] [Full Text] [Related]

  • 8. Expression of Ki-67, cyclin D1 and apoptosis markers correlated with survival in prostate cancer patients treated by radical prostatectomy.
    Aaltomaa S, Kärjä V, Lipponen P, Isotalo T, Kankkunen JP, Talja M, Mokka R.
    Anticancer Res; 2006 Mar 15; 26(6C):4873-8. PubMed ID: 17214354
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of the cell cycle inhibitor p16INK4A in high-grade prostatic intraepithelial neoplasia predicts early relapse in prostate cancer patients.
    Henshall SM, Quinn DI, Lee CS, Head DR, Golovsky D, Brenner PC, Delprado W, Stricker PD, Grygiel JJ, Sutherland RL.
    Clin Cancer Res; 2001 Mar 15; 7(3):544-50. PubMed ID: 11297246
    [Abstract] [Full Text] [Related]

  • 10. Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer.
    Zellweger T, Ninck C, Mirlacher M, Annefeld M, Glass AG, Gasser TC, Mihatsch MJ, Gelmann EP, Bubendorf L.
    Prostate; 2003 Apr 01; 55(1):20-9. PubMed ID: 12640657
    [Abstract] [Full Text] [Related]

  • 11. Expression of sialylated MUC1 in prostate cancer: relationship to clinical stage and prognosis.
    Arai T, Fujita K, Fujime M, Irimura T.
    Int J Urol; 2005 Jul 01; 12(7):654-61. PubMed ID: 16045558
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
    Tan N, Lane BR, Li J, Moussa AS, Soriano M, Jones JS.
    J Urol; 2008 Oct 01; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
    Zhang Q, Helfand BT, Jang TL, Zhu LJ, Chen L, Yang XJ, Kozlowski J, Smith N, Kundu SD, Yang G, Raji AA, Javonovic B, Pins M, Lindholm P, Guo Y, Catalona WJ, Lee C.
    Clin Cancer Res; 2009 May 15; 15(10):3557-67. PubMed ID: 19447876
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy.
    Pierorazio PM, Lambert SM, Matsukhani M, Sprenkle PC, McCann TR, Katz AE, Olsson CA, Benson MC, McKiernan JM.
    BJU Int; 2007 Nov 15; 100(5):1066-70. PubMed ID: 17784880
    [Abstract] [Full Text] [Related]

  • 20. Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival.
    Tollefson MK, Leibovich BC, Slezak JM, Zincke H, Blute ML.
    J Urol; 2006 Feb 15; 175(2):547-51. PubMed ID: 16406993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.